News & Events

Biometrik Riset Indonesia Strengthens Industry Partnerships Through Sponsorship at APSMI Event 2026

Bali, Indonesia – PT Biometrik Riset Indonesia participated as a sponsor at the Asia Pacific Self Medication Industry (APSMI) Event 2026, held in Bali on 29–31 October 2026. This participation reflects Biometrik’s ongoing commitment to strengthening its presence in the pharmaceutical industry and expanding its network of strategic partnerships across the Asia-Pacific region.

As an independent Contract Research Organization (CRO), Biometrik Riset Indonesia continues to build meaningful collaborations with pharmaceutical companies, research institutions, and other industry stakeholders. Through ...

PT Biometrik Riset Indonesia Appointed as CRO for Uremic Clearance Granules (UCG) Clinical Trial, Marking Milestone in Indonesia–China Research Collaboration

Jakarta, October 15, 2026 – PT Biometrik Riset Indonesia, an independent Contract Research Organization (CRO) specializing in clinical research and Bioequivalence (BE) studies, plays a key role in overseeing the clinical trial of Uremic Clearance Granules (UCG), a Traditional Chinese Medicine (TCM) product, officially launched at RSPAD Gatot Soebroto Puskesad, Jakarta, on October 15, 2026.

This clinical trial represents an important milestone in international clinical research collaboration between Indonesia and China, bringing together PT Intrada Subur Abadi (Indonesia), Consun Pharmaceutical...

ESCAPE THE ORDINARY: PT Biometrik Riset Indonesia Embraces Adventure in Ciwidey

Writer & Editor: Rizky Puspita Dewi

Ciwidey, West Java, October 8–10, 2026 — Three days of adventure, laughter, and unforgettable moments brought the team of PT Biometrik Riset Indonesia to the beautiful highlands of Ciwidey, West Java. Guided by the theme “ESCAPE THE ORDINARY: Break The Routine. Embrace The Adventure”, the company’s outing offered all employees a chance to step away from their daily routines, discover new experiences, and reconnect beyond the workplace.

The program featured team building and fun games designed to strengthen collaboration, communication, and trust among colle...

Biometrik's LC-MS/MS Capabilities Continue to Grow with Industry Demands

Writer & Editor: Suci Rahma Yani

Biometrik continues to strengthen its bioanalytical capabilities to support the evolving analytical needs of the pharmaceutical industry. Equipped with five LC-MS/MS instruments, Biometrik has validated analytical methods for more than 150 molecules to date, with its method portfolio continuing to expand in response to market demand and the development of new pharmaceutical products.

Through continuous method development and validation, Biometrik supports a broad range of bioanalytical requirements, from single-drug compounds to combination products containing ...

Marking 12 Years of Growth: PT Biometrik Riset Indonesia Anniversary Celebration

Writer: Salma Dewina Salimah

Depok, August 31, 2026 – PT Biometrik Riset Indonesia marked its 12th anniversary with a celebratory company lunch, bringing together employees to reflect on the company's journey and look ahead to the road forward. The event opened with a company update from apt. Dra. Effi Setiawati, M.M., M.Biomed., Operational Director, who shared highlights of the year's achievements and outlined the company's strategic priorities for the year ahead. Her remarks were followed by a moment of collective reflection and prayer, expressing hope for continued success in reaching the...

PT BIOMETRIK RISET INDONESIA AT CPHI KOREA 2026: THE LEADING COMPANY IN BIOEQUIVALENCE STUDY GOES GLOBAL

Writer & Editor: Canaya Vania Rehansha

Seoul, August 2026 – PT BIOMETRIK RISET INDONESIA AT CPHI KOREA 2026: THE LEADING COMPANY IN BIOEQUIVALENCE STUDY GOES GLOBAL

Strengthening Global Connections and Exploring New Collaborations

Seoul, South Korea – PT Biometrik Riset Indonesia successfully concluded its participation at CPHI Korea 2026, strengthening its presence as The Leading Company in Bioequivalence Study and expanding its network within the global pharmaceutical industry.

Throughout the event, the Biometrik team actively connected with pharmaceutical companies and industry professional...

Biometrik Conducts Disaster Mitigation Training in Collaboration with UPT Damkar Cimanggis

Writer: Ega Astiana Nuzul Wahyuni ; Editor: Oktaviani Utami Dewi

On Monday, June 29, 2026, PT Biometrik Riset Indonesia, in collaboration with the UPT Pemadam Kebakaran Kecamatan Cimanggis, conducted an in-house Disaster Mitigation Training for all employees. The initiative was designed to strengthen emergency preparedness, improve disaster response capabilities, and ensure the safety of both employees and study subjects involved in Bioequivalence (BE) studies.

The training combined classroom instruction with practical exercises. During the theoretical session, participants learned about f...

Biometrik Riset Indonesia participated in the HISFARIN East Java

Writer & Editor: Padantya Narastiti Putri S

Surabaya, 4th July: PT Biometrik Riset Indonesia participated in the HISFARIN (Himpunan Seminat Farmasi Industri) East Java at Mercure Surabaya Grand Mirama. During the event, Biometrik welcomed participants at its exhibition booth, providing insights into the company’s bioequivalence and bioanalytical services.

In addition, a representative from Biometrik was invited as a speaker to deliver a presentation entitled “Critical Success Factors in Bioequivalence Studies: A Bioanalytical Laboratory Perspective.” The session highlighted key considerations...

Biometrik Medical Laboratory – PT Biometrik Riset Indonesia Officially Achieves SNI ISO 15189:2022 Accreditation

Writer & Editor: Tomi Saputra

Depok, June 2026 – PT Biometrik Riset Indonesia is proud to announce that Biometrik Medical Laboratory has officially achieved SNI ISO 15189:2022 Accreditation, demonstrating its technical competence as a medical laboratory and its implementation of a quality management system that complies with both national and international standards.

This accreditation is valid for five years, from March 17, 2026, to March 16, 2031, and reflects the company's commitment to delivering accurate, reliable, and trustworthy laboratory testing services.

The scope of the accreditatio...

Biometrik Riset Indonesia Takes Another Step Forward Toward the International Stage

Writer & Editor: dr. Natalia D (Responsible Physician)

Depok, May 2026 : In May 2026, PT Biometrik Riset Indonesia was presented with both an opportunity and a challenge to further expand its presence on the international stage through an inspection conducted by NPRA auditors from a neighboring country, Malaysia.

Extensive preparations had been carried out since the beginning of 2026. These preparations included reviewing and analyzing all aspects within the scope of the inspection, ranging from quality manuals, standard operating procedures, and work instructions, to the readiness and perfor...